ATE472324T1 - Isosorbid-mononitrat-derivate zur behandlung von okularer hypertonie - Google Patents

Isosorbid-mononitrat-derivate zur behandlung von okularer hypertonie

Info

Publication number: ATE472324T1
Authority: AT; Austria
Prior art keywords: occular; hypertonia; treatment; isosorbide mononitrate; mononitrate derivatives
Prior art date: 2006-12-28

Application number

AT07858167T

Other languages

English (en)

Inventor

Moliner Jose Repolles

Coy Francisco Pubill

Mancini Marisabel Mourelle

Original Assignee

Lacer Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-12-28

Filing date

2007-12-27

Publication date

2010-07-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38043051&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE472324(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2007-12-27 Application filed by Lacer Sa filed Critical Lacer Sa

2010-07-15 Application granted granted Critical

2010-07-15 Publication of ATE472324T1 publication Critical patent/ATE472324T1/de

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

AT07858167T 2006-12-28 2007-12-27 Isosorbid-mononitrat-derivate zur behandlung von okularer hypertonie ATE472324T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP06380338A EP1941876A1 (de)	2006-12-28	2006-12-28	Isosorbidmononitrit Derivate zur Behandlung von der Inflammation und okularen Hypertension
PCT/EP2007/064570 WO2008080939A1 (en)	2006-12-28	2007-12-27	Isosorbide mononitrate derivatives for the treatment of ocular hypertension

Publications (1)

Publication Number	Publication Date
ATE472324T1 true ATE472324T1 (de)	2010-07-15

Family

ID=38043051

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
AT07858187T ATE484279T1 (de)	2006-12-28	2007-12-27	Isosorbid-mononitrat-derivate zur behandlung von darmerkrankungen
AT07858167T ATE472324T1 (de)	2006-12-28	2007-12-27	Isosorbid-mononitrat-derivate zur behandlung von okularer hypertonie

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
AT07858187T ATE484279T1 (de)	2006-12-28	2007-12-27	Isosorbid-mononitrat-derivate zur behandlung von darmerkrankungen

Country Status (21)

Country	Link
US (1)	US20080161389A1 (de)
EP (3)	EP1941876A1 (de)
JP (2)	JP2010514734A (de)
KR (2)	KR20100100584A (de)
CN (2)	CN101600425A (de)
AR (1)	AR064543A1 (de)
AT (2)	ATE484279T1 (de)
AU (2)	AU2007341218B2 (de)
BR (2)	BRPI0720664A2 (de)
CA (2)	CA2674144A1 (de)
CL (2)	CL2007003837A1 (de)
DE (2)	DE602007009877D1 (de)
ES (3)	ES2324130B1 (de)
IL (2)	IL198912A0 (de)
MX (2)	MX2009007038A (de)
NO (2)	NO20092763L (de)
PL (2)	PL2124930T3 (de)
RU (2)	RU2009128968A (de)
UY (1)	UY30847A1 (de)
WO (2)	WO2008080955A1 (de)
ZA (2)	ZA200903566B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2149577B1 (de) *	2008-07-22	2011-04-27	Lacer, S.A.	Neues stereospezifisches Verfahren zur Herstellung von Dioxabicyclooctan-Verbindungen
EP2149576A1 (de) *	2008-07-22	2010-02-03	Lacer, S.A.	Isosorbitnitrate mit vasodilatierender Wirksamkeit
EP2177216A1 (de) *	2008-10-13	2010-04-21	Lacer, S.A.	Verwendung von Dianhydrohexit-Mononitrat-Derivaten als Heilungsmittel
WO2010055138A1 (en) *	2008-11-14	2010-05-20	Lacer, S.A.	New stereospecific method for the preparation of dioxa-bicyclooctane compounds
EP2199294A1 (de) *	2008-12-19	2010-06-23	Lacer, S.A.	Neues stereoskopisches Verfahren zur Herstellung von Dioxa-Bicyclooctan-Nitratverbindungen
DK2515899T3 (en) *	2009-12-23	2016-08-15	Arca Biopharma Inc	METHODS AND COMPOSITIONS FOR CARDIOVASCULAR DISEASES AND CONDITIONS
KR20150123324A (ko) *	2013-03-05	2015-11-03	아처 다니엘 미드랜드 캄파니	이소헥시드 모노트리플레이트 및 이의 합성 방법
WO2018224419A1 (en)	2017-06-06	2018-12-13	Nicox S.A.	Nitric oxide donating isomannide derivatives

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2739689C2 (de) *	1977-09-02	1986-10-16	Euratom	Thermische Wärmepumpe
JPS60149521A (ja) *	1984-01-18	1985-08-07	Eisai Co Ltd	高眼圧・緑内障治療・予防用点眼剤
US5573758A (en) *	1995-04-28	1996-11-12	Allergan	Method for reducing intraocular pressure in the mammalian eye by administration of potassium channel blockers
US5925342A (en) *	1996-11-13	1999-07-20	Allergan	Method for reducing intraocular pressure in the mammalian eye by administration of potassium channel blockers
GB9720797D0 (en) *	1997-09-30	1997-12-03	Rhodes John	Pharmaceutical composition for the treatment of inflammatory bowel disease and irritable bowel syndrome
ES2142773B1 (es) *	1998-10-07	2001-01-01	Lacer Sa	Derivados de mononitrato de isosorbida y su empleo como agentes vasodilatadores con tolerancia desminuida.
US20040077664A1 (en) *	2001-01-31	2004-04-22	Hans-Michael Eggenweiler	Pharmaceutical formulation comprising pyrazolo[4,3-d]pyrimidine and nitrates or thienopyrimidines and nitrates
DE60326226D1 (de) *	2002-03-21	2009-04-02	Cayman Chemical Co	Prostaglandin f2 alpha analoga in kombination mit einem antimikrobiellen mittel zur behandlung von glaukom
JP2007504807A (ja) *	2003-09-08	2007-03-08	ボードオブリージェンツオブザユニバーシティーオブテキサスシステム	培養培地にプロスタグランジン又はプロスタグランジン類似物を補足することによってインビトロ胚発生を高めるための方法及び組成
ES2258365B1 (es) *	2003-10-03	2007-12-01	Lacer, S.A.	Derivados de disulfuro, sulfuro, sulfoxido y sulfona de azucares ciclicos y sus usos.

2006
- 2006-12-28 EP EP06380338A patent/EP1941876A1/de not_active Withdrawn
2007
- 2007-01-23 ES ES200700181A patent/ES2324130B1/es not_active Expired - Fee Related
- 2007-03-01 US US11/680,691 patent/US20080161389A1/en not_active Abandoned
- 2007-12-27 KR KR1020097015820A patent/KR20100100584A/ko not_active Application Discontinuation
- 2007-12-27 CA CA002674144A patent/CA2674144A1/en not_active Abandoned
- 2007-12-27 CN CNA2007800441623A patent/CN101600425A/zh active Pending
- 2007-12-27 MX MX2009007038A patent/MX2009007038A/es active IP Right Grant
- 2007-12-27 EP EP07858187A patent/EP2124930B1/de active Active
- 2007-12-27 MX MX2009007040A patent/MX2009007040A/es active IP Right Grant
- 2007-12-27 PL PL07858187T patent/PL2124930T3/pl unknown
- 2007-12-27 JP JP2009543474A patent/JP2010514734A/ja active Pending
- 2007-12-27 CL CL200703837A patent/CL2007003837A1/es unknown
- 2007-12-27 RU RU2009128968/15A patent/RU2009128968A/ru not_active Application Discontinuation
- 2007-12-27 AT AT07858187T patent/ATE484279T1/de not_active IP Right Cessation
- 2007-12-27 PL PL07858167T patent/PL2114398T3/pl unknown
- 2007-12-27 ZA ZA200903566A patent/ZA200903566B/xx unknown
- 2007-12-27 AR ARP070105911A patent/AR064543A1/es unknown
- 2007-12-27 JP JP2009543471A patent/JP2010514733A/ja active Pending
- 2007-12-27 ES ES07858167T patent/ES2348314T3/es active Active
- 2007-12-27 CL CL200703836A patent/CL2007003836A1/es unknown
- 2007-12-27 BR BRPI0720664-0A patent/BRPI0720664A2/pt not_active IP Right Cessation
- 2007-12-27 ES ES07858187T patent/ES2354317T3/es active Active
- 2007-12-27 DE DE602007009877T patent/DE602007009877D1/de active Active
- 2007-12-27 ZA ZA200903567A patent/ZA200903567B/xx unknown
- 2007-12-27 RU RU2009128970/15A patent/RU2009128970A/ru not_active Application Discontinuation
- 2007-12-27 CA CA002674550A patent/CA2674550A1/en not_active Abandoned
- 2007-12-27 EP EP07858167A patent/EP2114398B1/de active Active
- 2007-12-27 WO PCT/EP2007/064591 patent/WO2008080955A1/en active Application Filing
- 2007-12-27 AT AT07858167T patent/ATE472324T1/de not_active IP Right Cessation
- 2007-12-27 AU AU2007341218A patent/AU2007341218B2/en not_active Ceased
- 2007-12-27 BR BRPI0720663-1A patent/BRPI0720663A2/pt not_active IP Right Cessation
- 2007-12-27 KR KR1020097015821A patent/KR20090112673A/ko not_active Application Discontinuation
- 2007-12-27 UY UY30847A patent/UY30847A1/es not_active Application Discontinuation
- 2007-12-27 AU AU2007341289A patent/AU2007341289B2/en not_active Ceased
- 2007-12-27 CN CN2007800443012A patent/CN101600426B/zh not_active Expired - Fee Related
- 2007-12-27 DE DE602007007523T patent/DE602007007523D1/de active Active
- 2007-12-27 WO PCT/EP2007/064570 patent/WO2008080939A1/en active Application Filing
2009
- 2009-05-24 IL IL198912A patent/IL198912A0/en unknown
- 2009-05-25 IL IL198941A patent/IL198941A0/en unknown
- 2009-07-27 NO NO20092763A patent/NO20092763L/no not_active Application Discontinuation
- 2009-07-27 NO NO20092764A patent/NO20092764L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
ZA200903567B (en)	2010-08-25
US20080161389A1 (en)	2008-07-03
AR064543A1 (es)	2009-04-08
NO20092764L (no)	2009-07-27
ES2354317T3 (es)	2011-03-14
EP2124930B1 (de)	2010-10-13
CL2007003837A1 (es)	2008-07-11
ZA200903566B (en)	2010-08-25
ES2324130B1 (es)	2010-03-22
EP2114398A1 (de)	2009-11-11
EP1941876A1 (de)	2008-07-09
ES2324130A1 (es)	2009-07-30
AU2007341289B2 (en)	2010-08-26
BRPI0720664A2 (pt)	2014-01-14
CA2674550A1 (en)	2008-07-10
CA2674144A1 (en)	2008-07-10
NO20092763L (no)	2009-07-27
CN101600426A (zh)	2009-12-09
KR20100100584A (ko)	2010-09-15
CN101600425A (zh)	2009-12-09
UY30847A1 (es)	2008-05-31
AU2007341218B2 (en)	2010-09-09
PL2114398T3 (pl)	2010-11-30
AU2007341289A1 (en)	2008-07-10
AU2007341218A1 (en)	2008-07-10
JP2010514734A (ja)	2010-05-06
WO2008080955A1 (en)	2008-07-10
MX2009007038A (es)	2009-08-25
KR20090112673A (ko)	2009-10-28
CL2007003836A1 (es)	2008-07-11
ES2348314T3 (es)	2010-12-02
IL198941A0 (en)	2010-02-17
WO2008080939A1 (en)	2008-07-10
RU2009128970A (ru)	2011-02-10
ATE484279T1 (de)	2010-10-15
MX2009007040A (es)	2009-08-25
DE602007009877D1 (de)	2010-11-25
EP2124930A1 (de)	2009-12-02
JP2010514733A (ja)	2010-05-06
EP2114398B1 (de)	2010-06-30
CN101600426B (zh)	2012-07-25
PL2124930T3 (pl)	2011-04-29
BRPI0720663A2 (pt)	2014-01-14
DE602007007523D1 (de)	2010-08-12
RU2009128968A (ru)	2011-02-10
IL198912A0 (en)	2010-02-17

Legal Events

Date	Code	Title	Description
2010-12-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
ATE527241T1 (de)	2011-10-15	Pyridiazinonderivate zur behandlung von tumoren
ATE550329T1 (de)	2012-04-15	Heterobicyclische sulfonamidderivate zur behandlung von diabetes
DE602005026984D1 (de)	2011-04-28	Chinolin-derivate zur behandlung von latenter tuberkulose
DE602005023172D1 (de)	2010-10-07	Hydantoinderivate zur behandlung von entzündlichen erkrankungen
ATE369333T1 (de)	2007-08-15	Sulfonamidderivate zur behandlung von krankheiten
ATE375977T1 (de)	2007-11-15	Sulfonamidderivate zur behandlung von krankheiten
ATE438623T1 (de)	2009-08-15	Aroyl-o-piperidinderivate zur behandlung von problemen im zusammenhang mit diabetes
ATE434620T1 (de)	2009-07-15	Dihydrothienopyrimidine zur behandlung von entzündlichen erkrankungen
DE602005007717D1 (de)	2008-08-07	Imidazolverbindungen zur behandlung von neurodegenerativen erkrankungen
ATE435271T1 (de)	2009-07-15	Zusammensetzungen zur wäschebehandlung
ATE430187T1 (de)	2009-05-15	Zusammensetzungen zur wäschebehandlung
ATE429218T1 (de)	2009-05-15	Pinolensäure zur behandlung von übergewicht
ATE550338T1 (de)	2012-04-15	Spiropiperidininhibitoren von beta-secretase zur behandlung von alzheimer-krankheit
DE602005017503D1 (de)	2009-12-17	Biphenyloxyessigsäure - derivate zur behandlung von atemwegserkränkungen
ATE493986T1 (de)	2011-01-15	Diarylharnstoffe zur behandlung von pulmonaler hypertonie
DE602006017980D1 (de)	2010-12-16	3,4-substituierte pyrrolidin-derivate zur behandlung von hypertonie
ATE534633T1 (de)	2011-12-15	Indazolderivate zur behandlung von hsp90- induzierten krankheiten
ATE472324T1 (de)	2010-07-15	Isosorbid-mononitrat-derivate zur behandlung von okularer hypertonie
DE602006003094D1 (de)	2008-11-20	4-phenyl-5-oxo-1,4,5,6,7,8-hexahydrochinolin-derivate zur behandlung von unfruchtbarkeit
ATE483460T1 (de)	2010-10-15	Amino-oxo-indolyliden-verbindungen zur verwendung in der behandlung von juckender kopfhaut
DE602006005640D1 (de)	2009-04-23	4-phenyl-5-oxo-1,4,5,6,7,8-hexahydrochinolin-derivate als arzneimittel zur behandlung von unfruchtbarkeit
DE602005016141D1 (de)	2009-10-01	S-mirtazapin zur behandlung von hitzewallungen
DE602006021192D1 (de)	2011-05-19	Visnadin zur Behandlung von Kopfhautjucken
DE602004021435D1 (de)	2009-07-16	Injizierbare zusammensetzung zur behandlung von krebs
ATE525355T1 (de)	2011-10-15	1-ä(4-äbenzoyl(methyl)aminoü-3- (phenyl)butylüazetidinderivate zur behandlung von gastrointestinalen erkrankungen 1